Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphoma

Cell Cycle. 2013 Jun 15;12(12):1811-2. doi: 10.4161/cc.25115. Epub 2013 May 24.
No abstract available

Keywords: DLBCL; drug resistance; gene expression profile; nucleotide excision DNA repair; prognosis; risk score.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Gene Expression Profiling*
  • Genetic Testing / methods*
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / genetics*

Substances

  • Biomarkers, Tumor